127 related articles for article (PubMed ID: 32717373)
1. Synthesis and matched molecular pair analysis of covalent reversible inhibitors of the cysteine protease CPB.
Matos TKB; Batista PHJ; Dos Reis Rocho F; de Vita D; Pearce N; Kellam B; Montanari CA; Leitão A
Bioorg Med Chem Lett; 2020 Sep; 30(18):127439. PubMed ID: 32717373
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA
Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787
[TBL] [Abstract][Full Text] [Related]
3. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors.
Cianni L; Sartori G; Rosini F; De Vita D; Pires G; Lopes BR; Leitão A; Burtoloso ACB; Montanari CA
Bioorg Chem; 2018 Sep; 79():285-292. PubMed ID: 29783099
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of warheads for design of cysteine protease inhibitors.
Silva DG; Ribeiro JFR; De Vita D; Cianni L; Franco CH; Freitas-Junior LH; Moraes CB; Rocha JR; Burtoloso ACB; Kenny PW; Leitão A; Montanari CA
Bioorg Med Chem Lett; 2017 Nov; 27(22):5031-5035. PubMed ID: 29054358
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.
Schirmeister T; Schmitz J; Jung S; Schmenger T; Krauth-Siegel RL; Gütschow M
Bioorg Med Chem Lett; 2017 Jan; 27(1):45-50. PubMed ID: 27890381
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds.
Fonseca Lameiro RD; Shamim A; Rosini F; Cendron R; Jatai Batista PH; Montanari CA
Future Med Chem; 2021 Jan; 13(1):25-43. PubMed ID: 33289603
[No Abstract] [Full Text] [Related]
7. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
[TBL] [Abstract][Full Text] [Related]
8. Active Site Mapping of Human Cathepsin F with Dipeptide Nitrile Inhibitors.
Schmitz J; Furtmann N; Ponert M; Frizler M; Löser R; Bartz U; Bajorath J; Gütschow M
ChemMedChem; 2015 Aug; 10(8):1365-77. PubMed ID: 26119278
[TBL] [Abstract][Full Text] [Related]
9. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K.
Robichaud J; Oballa R; Prasit P; Falgueyret JP; Percival MD; Wesolowski G; Rodan SB; Kimmel D; Johnson C; Bryant C; Venkatraman S; Setti E; Mendonca R; Palmer JT
J Med Chem; 2003 Aug; 46(17):3709-27. PubMed ID: 12904076
[TBL] [Abstract][Full Text] [Related]
10. Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L.
Ehmke V; Winkler E; Banner DW; Haap W; Schweizer WB; Rottmann M; Kaiser M; Freymond C; Schirmeister T; Diederich F
ChemMedChem; 2013 Jun; 8(6):967-75. PubMed ID: 23658062
[TBL] [Abstract][Full Text] [Related]
11. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
12. Nitrile-based peptoids as cysteine protease inhibitors.
Alves L; Santos DA; Cendron R; Rocho FR; Matos TKB; Leitão A; Montanari CA
Bioorg Med Chem; 2021 Jul; 41():116211. PubMed ID: 33991733
[TBL] [Abstract][Full Text] [Related]
13. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.
Ehmke V; Quinsaat JE; Rivera-Fuentes P; Heindl C; Freymond C; Rottmann M; Brun R; Schirmeister T; Diederich F
Org Biomol Chem; 2012 Aug; 10(30):5764-8. PubMed ID: 22336919
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
[TBL] [Abstract][Full Text] [Related]
16. Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins.
Nizi E; Sferrazza A; Fabbrini D; Nardi V; Andreini M; Graziani R; Gennari N; Bresciani A; Paonessa G; Harper S
Bioorg Med Chem Lett; 2018 May; 28(9):1540-1544. PubMed ID: 29615344
[TBL] [Abstract][Full Text] [Related]
17. Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design.
Greenspan PD; Clark KL; Tommasi RA; Cowen SD; McQuire LW; Farley DL; van Duzer JH; Goldberg RL; Zhou H; Du Z; Fitt JJ; Coppa DE; Fang Z; Macchia W; Zhu L; Capparelli MP; Goldstein R; Wigg AM; Doughty JR; Bohacek RS; Knap AK
J Med Chem; 2001 Dec; 44(26):4524-34. PubMed ID: 11741472
[TBL] [Abstract][Full Text] [Related]
18. Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K.
Altmann E; Cowan-Jacob SW; Missbach M
J Med Chem; 2004 Nov; 47(24):5833-6. PubMed ID: 15537340
[TBL] [Abstract][Full Text] [Related]
19. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
Löser R; Schilling K; Dimmig E; Gütschow M
J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
[TBL] [Abstract][Full Text] [Related]
20. Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays.
Ren XF; Li HW; Fang X; Wu Y; Wang L; Zou S
Org Biomol Chem; 2013 Feb; 11(7):1143-8. PubMed ID: 23299878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
